Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis
(2022) Alimentary Pharmacology and Therapeutics — Vol. 55, n° 7, p. 889-890 (2022)
Files
draft_Proof_hi2.pdf
Open Access - Adobe PDF
- 248.17 KB
Details
- Authors
Spahr, Laurent 
- Abstract
- (en) We read with great interest the study by Ewan Forrest and his colleagues. They analysed the liver biopsies from the STOPAH trial.1 As a reminder, recruitment to the trial was based on a clinical diagnosis of severe alcoholic hepatitis (AH). A liver biopsy was not required for inclusion. Out of 1068 patients included, 182 had a biopsy (17%). One hundred and sixty-two were suitable for histological evaluation and 140 were diagnostic for alcoholic steatohepatitis (ASH). [...]
- Affiliations
Hôpitaux universitaires de Genève Hepatology and Gastroenterology
Citations
Lanthier, N., & Spahr, L. (2022). Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis. Alimentary Pharmacology and Therapeutics, 55(7), 889-890. https://doi.org/10.1111/apt.16835 (Original work published 2022)